Perrigo Company plc (PIG) - Net Assets

Latest as of September 2025: €4.45 Billion EUR ≈ $5.20 Billion USD

Based on the latest financial reports, Perrigo Company plc (PIG) has net assets worth €4.45 Billion EUR (≈ $5.20 Billion USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€10.08 Billion ≈ $11.79 Billion USD) and total liabilities (€5.64 Billion ≈ $6.59 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read Perrigo Company plc (PIG) financial obligations for a breakdown of total debt and financial obligations.

Key Net Assets Metrics

Metric Value
Current Net Assets €4.45 Billion
% of Total Assets 44.09%
Annual Growth Rate -3.94%
5-Year Change -23.62%
10-Year Change N/A
Growth Volatility 4.75

Perrigo Company plc - Net Assets Trend (2016–2024)

This chart illustrates how Perrigo Company plc's net assets have evolved over time, based on quarterly financial data. Also explore Perrigo Company plc balance sheet assets for the complete picture of this company's asset base.

Annual Net Assets for Perrigo Company plc (2016–2024)

The table below shows the annual net assets of Perrigo Company plc from 2016 to 2024. For live valuation and market cap data, see Perrigo Company plc stock valuation.

Year Net Assets Change
2024-12-31 €4.32 Billion
≈ $5.05 Billion
-9.41%
2023-12-31 €4.77 Billion
≈ $5.57 Billion
-1.53%
2022-12-31 €4.84 Billion
≈ $5.66 Billion
-6.01%
2021-12-31 €5.15 Billion
≈ $6.02 Billion
-8.90%
2020-12-31 €5.66 Billion
≈ $6.61 Billion
-2.57%
2019-12-31 €5.80 Billion
≈ $6.79 Billion
+2.40%
2018-12-31 €5.67 Billion
≈ $6.63 Billion
-8.14%
2017-12-31 €6.17 Billion
≈ $7.21 Billion
+3.58%
2016-12-31 €5.96 Billion
≈ $6.97 Billion
--

Equity Component Analysis

This analysis shows how different components contribute to Perrigo Company plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 15700000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Other Components €6.57 Billion 152.14%
Total Equity €4.32 Billion 100.00%

Perrigo Company plc Competitors by Market Cap

The table below lists competitors of Perrigo Company plc ranked by their market capitalization.

Company Market Cap
Bukit Uluwatu Villa Tbk
JK:BUVA
$1.51 Billion
Harrow Health Inc
NASDAQ:HROW
$1.51 Billion
Guangdong Homa Appliances Co Ltd
SHE:002668
$1.52 Billion
Hyundai Green Food Co Ltd
KO:005440
$1.52 Billion
Thai Union Group Public Company Limited
BK:TU-R
$1.51 Billion
Jiangxi Ganyue Expressway Co Ltd
SHG:600269
$1.51 Billion
Maharashtra Scooters Limited
NSE:MAHSCOOTER
$1.51 Billion
Telecom Argentina S.A
F:TEO
$1.51 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Perrigo Company plc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 4,767,900,000 to 4,319,400,000, a change of -448,500,000 (-9.4%).
  • Net loss of 171,800,000 reduced equity.
  • Dividend payments of 152,500,000 reduced retained earnings.
  • Other factors decreased equity by 124,200,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income €-171.80 Million -3.98%
Dividends Paid €152.50 Million -3.53%
Other Changes €-124.20 Million -2.88%
Total Change €- -9.41%

Book Value vs Market Value Analysis

This analysis compares Perrigo Company plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.30x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-12-31 €43.82 €9.48 x
2018-12-31 €41.71 €9.48 x
2019-12-31 €42.64 €9.48 x
2020-12-31 €42.49 €9.48 x
2021-12-31 €38.50 €9.48 x
2022-12-31 €35.95 €9.48 x
2023-12-31 €35.19 €9.48 x
2024-12-31 €31.66 €9.48 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Perrigo Company plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -3.98%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -3.93%
  • • Asset Turnover: 0.45x
  • • Equity Multiplier: 2.23x
  • Recent ROE (-3.98%) is above the historical average (-7.99%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2016 -67.35% -75.99% 0.38x 2.33x €-4.61 Billion
2017 1.94% 2.42% 0.43x 1.88x €-497.45 Million
2018 2.31% 2.77% 0.43x 1.94x €-435.80 Million
2019 2.52% 3.02% 0.43x 1.95x €-434.28 Million
2020 -2.88% -3.21% 0.44x 2.03x €-728.11 Million
2021 -1.34% -1.66% 0.40x 2.02x €-584.07 Million
2022 -2.90% -3.16% 0.40x 2.28x €-624.81 Million
2023 -0.27% -0.27% 0.43x 2.27x €-489.49 Million
2024 -3.98% -3.93% 0.45x 2.23x €-603.74 Million

Industry Comparison

This section compares Perrigo Company plc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $676,868,481
  • Average return on equity (ROE) among peers: -100.00%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Perrigo Company plc (PIG) €4.45 Billion -67.35% 1.27x $1.51 Billion
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) $5.52 Billion 11.33% 0.42x $635.99 Million
AYURCANN HOLDINGS CORP. (3ZQ0) $534.88K -741.80% 26.77x $113.81K
LORDS CO. WORLDW. HOLD. (4XM) $-1.01 Million 0.00% 0.00x $134.78K
EQL PHARMA AB (7JK) $123.63 Million 25.52% 0.92x $148.83 Million
Alkermes plc (8AK) $1.11 Billion -4.33% 0.82x $5.00 Billion
OPTIMI HEALTH CORP. (8BN) $6.57 Million -56.49% 1.32x $17.99 Million
LABIANA HEALTH S.A.EO-10 (8RK) $2.57 Million 9.87% 19.25x $40.60 Million
CANNABIS POLAND AB ZY-10 (8TE) $321.96K -209.89% 1.07x $1.75 Million
Apontis Pharma AG (APPH) $3.46 Million -34.21% 7.59x $91.63 Million
CRAFTPORT CANNABIS CORP. (BBW0) $-3.18 Million 0.00% 0.00x $1.45 Million

About Perrigo Company plc

F:PIG Germany Drug Manufacturers - Specialty & Generic
Market Cap
$1.52 Billion
€1.30 Billion EUR
Market Cap Rank
#7344 Global
#1019 in Germany
Share Price
€9.48
Change (1 day)
-2.35%
52-Week Range
€7.82 - €24.30
All Time High
€125.23
About

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nut… Read more